Archive

CHEPLAPHARM continues its rapid growth: 50% sales increase in 2013 compared to the previous year.

Additionally, CHEPLAPHARM acquires Glenwood LLC based in New York, USA.

CHEPLAPHARM continues its rapid growth in 2013. The increase in sales...

Read more

CHEPLAPHARM acquires the rights for VESANOID® and ROHYPNOL® - largest investment since company´s existence.

Products are attained from F. Hoffmann-La Roche and will be exported to more than 90 countries.

Mesekenhagen-based CHEPLAPHARM Arzneimittel GmbH from...

Read more

CHEPLAPHARM attains the rights for HEMINEVRIN®/DISTRANEURIN®

Pharmaceutical product was taken over from AstraZeneca and is distributed in Europe

CHEPLAPHARM, headquartered in Mesekenhagen (Mecklenburg-Western...

Read more